TNGX: Tango Therapeutics Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Tango Therapeutics Inc (TNGX).

OverviewDividends

$331.92M Market Cap.

As of 05/12/2025 5:00 PM ET (MRY) • Disclaimer

TNGX Market Cap. (MRY)


TNGX Shares Outstanding (MRY)


TNGX Assets (MRY)


Total Assets

$316.49M

Total Liabilities

$116.97M

Total Investments

$190.95M

TNGX Income (MRY)


Revenue

$42.07M

Net Income

-$130.30M

Operating Expense

$187.66M

TNGX Cash Flow (MRY)


CF Operations

-$131.50M

CF Investing

$86.13M

CF Financing

$47.66M

TNGX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$316,492,000 (-21.38%)

$402,567,000 (-7.77%)

$436,470,000 (-12.73%)

$500,155,000 (141.33%)

Assets Current

$266,343,000 (-23.14%)

$346,538,000 (-7.66%)

$375,272,000 (-23.78%)

$492,338,000 (154.26%)

Assets Non-Current

$50,149,000 (-10.49%)

$56,029,000 (-8.45%)

$61,198,000 (682.88%)

$7,817,000 (-42.61%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$199,517,000 (-21.17%)

$253,108,000 (1.46%)

$249,476,000 (-27.64%)

$344,747,000 (793.13%)

Property Plant & Equipment Net

$47,578,000 (-10.93%)

$53,416,000 (-7.54%)

$57,770,000 (849.23%)

$6,086,000 (-46.16%)

Cash & Equivalents

$69,530,000 (3.40%)

$67,241,000 (11.08%)

$60,535,000 (-57.76%)

$143,312,000 (404.96%)

Accumulated Other Comprehensive Income

$336,000 (80.65%)

$186,000 (105.02%)

-$3,705,000 (-384.31%)

-$765,000 (-4600.00%)

Deferred Revenue

$62,384,000 (-32.45%)

$92,353,000 (-25.45%)

$123,880,000 (-11.98%)

$140,740,000 (-7.88%)

Total Investments

$190,954,000 (-30.07%)

$273,067,000 (-11.80%)

$309,588,000 (-10.06%)

$344,222,000 (109.61%)

Investments Current

$188,387,000 (-30.36%)

$270,500,000 (-11.65%)

$306,165,000 (-10.61%)

$342,510,000 (111.51%)

Investments Non-Current

$2,567,000 (0.00%)

$2,567,000 (-25.01%)

$3,423,000 (99.94%)

$1,712,000 (-24.88%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$2,000,000 (0.00%)

$2,000,000 (0.00%)

Trade & Non-Trade Payables

$1,601,000 (-42.51%)

$2,785,000 (-37.46%)

$4,453,000 (38.03%)

$3,226,000 (75.23%)

Accumulated Retained Earnings (Deficit)

-$501,558,000 (-35.10%)

-$371,256,000 (-37.75%)

-$269,512,000 (-67.05%)

-$161,336,000 (-56.48%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$35,000 (-32.69%)

$52,000 (0%)

Total Debt

$36,493,000 (-6.24%)

$38,920,000 (-5.38%)

$41,131,000 (2636.59%)

$1,503,000 (-80.94%)

Debt Current

$2,454,000 (17.87%)

$2,082,000 (17.63%)

$1,770,000 (17.76%)

$1,503,000 (56.73%)

Debt Non-Current

$34,039,000 (-7.60%)

$36,838,000 (-6.41%)

$39,361,000 (0%)

$0 (0%)

Total Liabilities

$116,975,000 (-21.73%)

$149,459,000 (-20.07%)

$186,994,000 (20.32%)

$155,408,000 (-7.85%)

Liabilities Current

$38,170,000 (-16.91%)

$45,938,000 (-17.30%)

$55,545,000 (36.51%)

$40,690,000 (-0.55%)

Liabilities Non-Current

$78,805,000 (-23.88%)

$103,521,000 (-21.25%)

$131,449,000 (14.58%)

$114,718,000 (-10.19%)

TNGX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$42,069,000 (15.17%)

$36,527,000 (46.93%)

$24,860,000 (-32.89%)

$37,042,000 (383.83%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$43,746,000 (23.22%)

$35,502,000 (18.24%)

$30,025,000 (70.64%)

$17,596,000 (78.37%)

Research & Development Expense

$143,918,000 (24.93%)

$115,198,000 (8.77%)

$105,906,000 (36.41%)

$77,636,000 (55.30%)

Operating Expenses

$187,664,000 (24.53%)

$150,700,000 (10.87%)

$135,931,000 (42.74%)

$95,232,000 (59.10%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$208,000 (55.22%)

$134,000 (148.15%)

$54,000 (-81.51%)

$292,000 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$130,302,000 (-28.07%)

-$101,744,000 (5.95%)

-$108,176,000 (-85.76%)

-$58,235,000 (-12.05%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$130,302,000 (-28.07%)

-$101,744,000 (5.95%)

-$108,176,000 (-85.76%)

-$58,235,000 (-12.05%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$130,302,000 (-28.07%)

-$101,744,000 (5.95%)

-$108,176,000 (-85.76%)

-$58,235,000 (-12.05%)

Weighted Average Shares

$109,226,731 (15.50%)

$94,572,448 (7.69%)

$87,820,037 (41.40%)

$62,108,032 (94.50%)

Weighted Average Shares Diluted

$109,226,731 (15.50%)

$94,572,448 (7.69%)

$87,820,037 (41.40%)

$62,108,032 (94.50%)

Earning Before Interest & Taxes (EBIT)

-$130,094,000 (-28.03%)

-$101,610,000 (6.02%)

-$108,122,000 (-86.60%)

-$57,943,000 (-11.49%)

Gross Profit

$42,069,000 (15.17%)

$36,527,000 (46.93%)

$24,860,000 (-32.89%)

$37,042,000 (383.83%)

Operating Income

-$145,595,000 (-27.52%)

-$114,173,000 (-2.79%)

-$111,071,000 (-90.88%)

-$58,190,000 (-11.48%)

TNGX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$86,126,000 (107.90%)

$41,426,000 (56.92%)

$26,399,000 (114.39%)

-$183,434,000 (-26.10%)

Net Cash Flow from Financing

$47,664,000 (-42.16%)

$82,406,000 (5002.54%)

$1,615,000 (-99.55%)

$357,325,000 (341.77%)

Net Cash Flow from Operations

-$131,501,000 (-11.46%)

-$117,982,000 (-8.16%)

-$109,080,000 (-83.24%)

-$59,527,000 (-184.95%)

Net Cash Flow / Change in Cash & Cash Equivalents

$2,289,000 (-60.87%)

$5,850,000 (107.22%)

-$81,066,000 (-170.88%)

$114,364,000 (1982.37%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$86,880,000 (102.27%)

$42,952,000 (25.99%)

$34,091,000 (118.77%)

-$181,597,000 (-25.83%)

Capital Expenditure

-$754,000 (50.59%)

-$1,526,000 (80.16%)

-$7,692,000 (-318.73%)

-$1,837,000 (-66.09%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$47,664,000 (-41.84%)

$81,958,000 (4949.78%)

$1,623,000 (-99.50%)

$327,335,000 (818237.50%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$28,897,000 (51.46%)

$19,079,000 (34.08%)

$14,230,000 (81.67%)

$7,833,000 (344.05%)

Depreciation Amortization & Accretion

$6,244,000 (3.70%)

$6,021,000 (49.48%)

$4,028,000 (104.88%)

$1,966,000 (20.98%)

TNGX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-309.70% (-11.20%)

-278.50% (35.99%)

-435.10% (-176.78%)

-157.20% (76.84%)

EBITDA Margin

-294.40% (-12.50%)

-261.70% (37.50%)

-418.70% (-177.10%)

-151.10% (77.02%)

Return on Average Equity (ROAE)

-55.40% (-31.90%)

-42.00% (-10.82%)

-37.90% (20.38%)

-47.60% (-104.21%)

Return on Average Assets (ROAA)

-35.80% (-42.06%)

-25.20% (-5.88%)

-23.80% (-50.63%)

-15.80% (60.00%)

Return on Sales (ROS)

-309.20% (-11.14%)

-278.20% (36.03%)

-434.90% (-178.07%)

-156.40% (76.96%)

Return on Invested Capital (ROIC)

-43.00% (-40.52%)

-30.60% (4.67%)

-32.10% (-20.22%)

-26.70% (59.11%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.6 (71.67%)

-9.17 (-55.53%)

-5.89 (49.36%)

-11.64 (-65.83%)

Price to Sales Ratio (P/S)

8.02 (-68.70%)

25.63 (0.08%)

25.61 (39.62%)

18.34 (-61.56%)

Price to Book Ratio (P/B)

1.66 (-58.29%)

3.99 (55.64%)

2.56 (-7.74%)

2.78 (-56.16%)

Debt to Equity Ratio (D/E)

0.59 (-0.68%)

0.59 (-21.33%)

0.75 (66.30%)

0.45 (-89.68%)

Earnings Per Share (EPS)

-1.19 (-10.19%)

-1.08 (12.20%)

-1.23 (-30.85%)

-0.94 (42.33%)

Sales Per Share (SPS)

0.39 (-0.26%)

0.39 (36.40%)

0.28 (-52.52%)

0.6 (148.33%)

Free Cash Flow Per Share (FCFPS)

-1.21 (4.19%)

-1.26 (4.96%)

-1.33 (-34.62%)

-0.99 (-145.74%)

Book Value Per Share (BVPS)

1.83 (-31.73%)

2.68 (-5.81%)

2.84 (-48.82%)

5.55 (359.14%)

Tangible Assets Book Value Per Share (TABVPS)

2.9 (-31.92%)

4.26 (-14.35%)

4.97 (-38.28%)

8.05 (24.08%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (80.00%)

-10 (-100.00%)

-5 (61.54%)

-13 (-160.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.56 (75.33%)

-10.36 (-86.11%)

-5.56 (58.89%)

-13.54 (-180.42%)

Asset Turnover

0.12 (27.47%)

0.09 (65.45%)

0.06 (-45.54%)

0.1 (74.14%)

Current Ratio

6.98 (-7.50%)

7.54 (11.66%)

6.76 (-44.17%)

12.1 (155.71%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$132,255,000 (-10.67%)

-$119,508,000 (-2.34%)

-$116,772,000 (-90.29%)

-$61,364,000 (-188.97%)

Enterprise Value (EV)

$316,399,058 (-68.03%)

$989,814,990 (70.91%)

$579,134,816 (-23.57%)

$757,685,944 (211.80%)

Earnings Before Tax (EBT)

-$130,094,000 (-28.03%)

-$101,610,000 (6.02%)

-$108,122,000 (-86.60%)

-$57,943,000 (-11.49%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$123,850,000 (-29.57%)

-$95,589,000 (8.17%)

-$104,094,000 (-85.96%)

-$55,977,000 (-11.18%)

Invested Capital

$245,285,000 (-25.29%)

$328,308,000 (-9.19%)

$361,521,000 (13.81%)

$317,656,000 (117.81%)

Working Capital

$228,173,000 (-24.09%)

$300,600,000 (-5.98%)

$319,727,000 (-29.21%)

$451,648,000 (195.75%)

Tangible Asset Value

$316,492,000 (-21.38%)

$402,567,000 (-7.77%)

$436,470,000 (-12.73%)

$500,155,000 (141.33%)

Market Capitalization

$331,921,058 (-67.13%)

$1,009,697,990 (57.94%)

$639,285,816 (-33.25%)

$957,757,944 (291.63%)

Average Equity

$235,203,000 (-3.00%)

$242,478,000 (-15.04%)

$285,402,000 (133.04%)

$122,468,500 (2763.81%)

Average Assets

$364,145,500 (-9.75%)

$403,464,250 (-11.35%)

$455,137,500 (23.71%)

$367,911,000 (179.76%)

Invested Capital Average

$302,239,000 (-8.83%)

$331,524,000 (-1.50%)

$336,578,000 (55.34%)

$216,675,750 (172.34%)

Shares

107,417,818 (5.32%)

101,989,696 (15.66%)

88,177,354 (0.72%)

87,546,430 (309.53%)